Table 3.

The objective response rate(ORR)and the disease control rate (DCR) of patients treated with pemetrexed-based therapy in four groups

	HER2	EGFR	ALK/ROS1	KRAS	P value
n	25	74	39	40
ORR%	36.0	33.8	41.3	35.0	0.896
DCR%	92.0	78.4	87.2	72.5	0.139